DOC vs REGN
Healthpeak Properties Inc (DOC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Healthpeak Properties Inc (DOC) is a reit - healthcare facilities company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DOC revenue for 2024-12-31 was $2.70B. Net income was $267.3M. Revenue was up 23.8% from 2023-12-31 to 2024-12-31. DOC currently screens at market cap $13.64B and trailing P/E 61.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DOC currently screens at market cap $13.64B and trailing P/E 61.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DOC and REGN stock pages for the full models.
Not investment advice.